Pattern of Daily Steps is Associated with Weight Loss: Secondary Analysis from the Step-Up Randomized Trial
If you have NASH without diabetes or obesity, approval requires submitting a prior authorization with: Biopsy or imaging confirmation of NASH with fibrosis stage F2 or higher Documentation of failed standard treatments (vitamin E, pioglitazone, lifestyle modification for at least 6 months) Peer-reviewed evidence supporting GLP-1 use in NASH A letter of medical necessity from a hepatologist or gastroenterologist Approval rate: 15-25% on first submission, 30-40% after appeal with additional specialist documentation
Approaches to improvements in efficacy primarily target additional gut hormones via dual- and tri-agonists, and if Mounjaro provides any indication, dual- and tri-agonists may not be likely to enhance tolerability
Those are strong numbers for a single-agonist medication
Manufacturer savings cards (Novo Nordisk for Ozempic/Wegovy, Eli Lilly for Mounjaro/Zepbound) require that you have commercial insurance covering the medication
But just how does glutathione help your body and mind
